Our Exosome-Depleted Fetal Bovine Serum (FBS) is designed to enhance the accuracy and efficiency of your research by significantly reducing exosome interference. Using a proprietary depletion protocol, we remove at least 95% of exosomes, ensuring that your experimental results reflect cellular activity rather than FBS-derived exosomes.

Key Features:

• Validated Exosome Depletion: The depletion rate is measured using Nanoparticle Tracking Analysis (NTA) with the NanoSight NS300 (Malvern), confirming consistent and effective removal.
• Preserves Essential Nutrients: Despite exosome removal, the serum retains all vital nutrients required for optimal cell culture performance.
• Consistent Performance Across Batches: Our treatment method ensures uniform exosome depletion, maintaining reliability across different serum batches.

FBS naturally contains exosomes that can interfere with research by influencing experimental outcomes. While the biological functions of these exosomes remain partially unknown, they are known to interact with exosomes secreted by cultured cells, potentially skewing results. With our exosome-depleted FBS, you eliminate this variable without compromising cell culture viability.